NCT03489070View on ClinicalTrials.gov

Traumastem® Versus Surgicel® for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

June 12, 2018

Study Completion Date

October 21, 2018

Conditions
Liver Hemorrhage
Interventions
COMBINATION_PRODUCT

Traumastem®

Intraoperative application as secondary hemostatic treatment

COMBINATION_PRODUCT

Surgicel®

Intraoperative application as secondary hemostatic treatment

Trial Locations (1)

110001

Hepatobiliary Surgery Department of the First Hosptial of China Medical University, Shenyang

All Listed Sponsors
lead

China Medical University, China

OTHER

NCT03489070 - Traumastem® Versus Surgicel® for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection | Biotech Hunter | Biotech Hunter